CSIMarket
 


Revolution Medicines Inc   (RVMD)
Other Ticker:  
 

Revolution Medicines Inc 's Long Term Debt to Equity

RVMD's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth


In the third quarter 2023 Revolution Medicines Inc did not have Long Term Debt.

Within Biotechnology & Pharmaceuticals industry Revolution Medicines Inc achieved the lowest Long Term Debt to Equity in the third quarter 2023. While total ranking remained the same in the third quarter 2023 compared to the previous quarter at no. .

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt RVMD´s has?
What is the structure of RVMD´s Equity?


RVMD Long Term Debt to Equity (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change 22.9 % 86.6 % 72.82 % 13.71 % 6.77 %
Y / Y Long Term Debt Change - - - - -
Long Term Debt to Equity MRQ - - - - -
RVMD's Total Ranking # # # # #
Seq. Equity Change -10.03 % -2.25 % 38.97 % 0.55 % 36.6 %
Seq. Long Term Debt Change - - - - -



Long Term Debt to Equity third quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #


Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
Revolution Medicines Inc 's Equity $ 837 Millions Visit RVMD's Balance sheet
Revolution Medicines Inc 's Long Term Debt $ 0 Millions Visit RVMD's Balance sheet
Source of RVMD's Sales Visit RVMD's Sales by Geography


Cumulative Revolution Medicines Inc 's Long Term Debt to Equity

RVMD's Long Term Debt to Equity for the trailling 12 Months

RVMD Long Term Debt to Equity

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity TTM Growth 22.9 % 86.6 % 72.82 % 13.71 % 6.77 %
Y / Y Long Term Debt TTM Growth - - - - -
Long Term Debt to Equity TTM - - - - -
Total Ranking TTM
Seq. Equity TTM Growth -10.03 % -2.25 % 38.97 % 0.55 % 36.6 %
Seq. Long Term Debt TTM Growth - - - - -


On the trailing twelve months basis During the twelve months ending III Quarter 2023 Revolution Medicines Inc did not have Long Term Debt .
Long Term Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry RVMD recorded the lowest Long Term Debt to Equity. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt RVMD´s has?
What is the structure of RVMD´s Equity?

TTM Long Term Debt to Equity Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Within the Market #


trailing twelve months Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Companies with similar Long Term Debt to Equity in the quarter ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry Long Term Debt to EquitySep 30 2023 MRQ Long Term DebtSep 30 2023 MRQ Equity

Date modified: 2023-11-07T13:08:53+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com